limaprost
Small moleculeexperimental
Clinical trial activity
2 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
1
Earliest trial started Feb 1, 2013 (NCT01888536)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 3 Sponsor(trial)
Indications
Approved for
Mechanism of action
- Prostaglandin E synthaseSupplementation
PTGES supplementation
Chemistry & pharmacology
Loading structure…
SMILES
CCCC[C@H](C)C[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC/C=C/C(=O)O- Mol. weight
- 380.53 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2107456 ↗
Also known as
- limaprost
- limaprost
- limaprost
- limaprost
- limaprost
- limaprost
- limaprost
- limaprost alfadex
- limaprost alfadex
- limaprost alpha-cyclodextrin clathrate
- limaprost alpha-cyclodextrin clathrate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02125981 | Phase 3 | Sep 1, 2014 | Seoul National University |
| NCT01888536 | Phase 4 | Feb 1, 2013 | Hallym University, Hanyang University, Inje University, Kyung Hee University, Seoul National University, Yonsei University, Yungjin Pharm. Co., Ltd. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Seoul National University | Academic/Hospital | 2 | 1 | 2 | 2013 |
| Hallym University | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Hanyang University | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Inje University | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Kyung Hee University | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Yonsei University | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Yungjin Pharm. Co., Ltd. | For profit | 1 | 1 | 1 | 2013 |
7 organizations
Page 1 / 1